Live Breaking News & Updates on Cutaneous Melanoma

Stay updated with breaking news from Cutaneous melanoma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Study Data from Castle Biosciences' Collaboration with the National Cancer Institute's SEER Program Registries Published in JCO Precision Oncology

Data shows testing with DecisionDx®-Melanoma provided significant prognostic information regarding survival outcomes ....

United States , Matthew Goldberg , Derek Maetzold , Castle Biosciences , Castle Biosciences Inc , Program Registries , American Joint Committee On Cancer Eighth Edition , Securities Exchange , American Joint Committee , Cancer Eighth Edition , Decisiondx Melanoma , Mypath Melanoma , Securities Act , Securities Exchange Act , Quarterly Report , Gene Expression Profile Testing , Cutaneous Melanoma , Survival Outcomes , Population Based Analysis ,

VA Study Finds Lower Racial Disparity in Melanoma Diagnoses

The results might be explained by "all patients in the VA dataset having insured access to health care, regardless of socioeconomic status," the authors wrote. ....

United States , Castle Biosciences , Travisw Blalock , Martina Weinstock , Rachelk Kim , End Results Program , Journal Of The American Academy Dermatology , Brown University , Emory University , Veterans Affairs , American Academy , Data Warehouse , Malignant Melanoma , Skin Cancer , Alignant Skin Neoplasm , Racial Ethnic Disparity , Social Determinants Of Health , Mohs Surgery , Mohs Micrographic Surgery , Distant Metastasis , Istant Metastases , Dermatologic Surgery , Urgery Dermatologic , Alignant Neoplasia , Elderly Concerns Of Older Adults , Cutaneous Melanoma ,

OncoAssure announces results of clinical study on novel prostate cancer test

OncoAssure today announced that results of its clinical study validating OncoAssure Prostate, a novel test for prostate cancer management, have been published in European Urology Focus, a peer-reviewed and open access journal. ....

William Gallagher , Anders Bjartell , Megan Craig , Cepheid Inc , Science Foundation Ireland , Prostate Cancer Research Consortium , Irish Cancer Society , Lund University , Oncoassure Prostate , European Urology Focus , Assure Prostate , Deso Leary , Professor William Gallagher , Cutaneous Melanoma , Squamous Cell , Chief Scientific Officer , Prostate Cancer , Professor William Watson , Professor Anders Bjartell , Prostate Cancer ,

Pembrolizumab Monotherapy Effective for Rare Melanoma

Pembrolizumab led to a dramatic overall response rate among patients with unresectable desmoplastic melanoma. ....

United States , Bristol Myers Squibb , Kari Kendra , Zeynep Aroglu , Ohio State University Wexner Medical Center , Boehringer Ingelheim , Washington University In St , Varian Medical Systems , Checkmate Pharmaceuticals , American Association For Cancer Research , American Association , Brian Van Tine , Washington University , Varian Medical , Van Tine , Malignant Melanoma , Skin Cancer , Alignant Skin Neoplasm , Biologic Therapy , Alignant Neoplasia , Neck Cervical Region Of , Elderly Concerns Of Older Adults , Cutaneous Melanoma , Geriatrics Elder Care , Neurofibromatosis Type 1 , Eurofibromatosis Typei Nf 1 ,

Pembrolizumab Yields High Response Rates for Patients With Unresectable Metastatic Desmoplastic Melanoma

Patients with unresectable metastatic desmoplastic melanoma achieved high response rates when treated with single-agent pembrolizumab in the SWOG S1512 trial, according to data presented during the 2023 AACR Annual Meeting. ....

United States , Castle Biosciences , Arthurg James , Kari Kendra , Iovance Biotherapeutics , Department Of Oncologic Sciences , Richardj Solove Research Institute , Ohio State University Comprehensive Cancer Center , American Society Of Clinical Oncology Annual Meeting , Cancer Hospital , Cutaneous Oncology , Moffitt Cancer Center , Oncologic Sciences , South Florida Morsani College , Clinical Oncology Annual Meeting , Instil Bio , Nresectable Metastatic Desmoplastic Melanoma , Aacr Annual Meeting , Cutaneous Melanoma , Swog S1512 Trial ,